People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits. Mary Faith Marshall, Medical School and Center for Bioethics, discusses ways to improve the informed consent process.
Read on Reuters, Chicago Tribune and FOX News
Leave a comment